Want to see IN:BALPHARMA full AI Analyst Report?
Bal Pharma Limited (BALPHARMA) Income Statement
Bal Pharma Limited Income Statement
Last quarter (Q1 2027), Bal Pharma Limited's total revenue was $886.16M, an increase of 34.53% from the same quarter last year. In Q1, Bal Pharma Limited's net income was $11.23M. See Bal Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 3.12B | $ 3.03B | $ 3.39B | $ 3.04B | $ 2.81B | |
| $ 761.52M | $ 730.18M | $ 770.20M | $ 1.25B | $ 1.11B | |
| $ 553.28M | $ 396.01M | $ 396.65M | $ 1.08B | $ 967.88M | |
| Depreciation and Amortization | $ 110.79M | $ 97.71M | $ 100.71M | $ 91.28M | $ 90.40M |
| $ 338.31M | $ 317.63M | $ 320.23M | $ 245.00M | $ 239.71M | |
| $ 208.24M | $ 197.89M | $ 214.57M | $ 177.23M | $ 149.18M | |
| $ -148.90M | $ -146.51M | $ -127.28M | $ -127.97M | $ -57.35M | |
| $ 59.34M | $ 51.38M | $ 90.47M | $ 47.48M | $ 91.83M | |
| $ 62.84M | $ 72.15M | $ 73.92M | $ 25.72M | $ 56.12M | |
| Per Share Metrics | |||||
| Basic EPS | $ 3.95 | $ 4.56 | $ 4.70 | $ 1.64 | $ 3.79 |
| Diluted EPS | $ 3.95 | $ 4.56 | $ 4.68 | $ 1.64 | $ 3.79 |
| Weighted Average Shares Outstanding | 15.91M | 14.58M | 14.96M | 15.69M | 14.82M |
| Weighted Average Shares Outstanding (Diluted) | 15.91M | 14.58M | 15.80M | 15.69M | 15.14M |
Currency in INR
